Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00743106 · ClinicalTrials.gov registry record · NA
The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00743106 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 90 participants.
The verdict
NCT00743106, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This trial will study the effects of fenoldopam on renal function in patients who have a single kidney undergoing surgery to remove part of that kidney secondary to renal cell carcinoma. The investigators will monitor and evaluate throughout the perioperative course the kidney function. Normally kidney function is predicted to show a worsening followed by an improvement after surgery. The investigators want to specifically identify if the use of fenoldopam lessens the injury to the kidney with this surgery.
Interventions
- DRUG Placebo
- DRUG Fenoldopam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-09 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00743106
The ClinicalTrials.gov registry entry for NCT00743106 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00743106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00743106 about?
NCT00743106 is a clinical study titled "The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery". This trial will study the effects of fenoldopam on renal function in patients who have a single kidney undergoing surgery to remove part of that kidney secondary to renal cell carcinoma. The investigators will monitor and evaluate throughout the perioperative course the kidney function. Normally kid...
What is the current status of trial NCT00743106?
This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 2002-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00743106?
The interventions under investigation include: Placebo (DRUG), Fenoldopam (DRUG).
Who is sponsoring clinical trial NCT00743106?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.